Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04645693 · ClinicalTrials.gov registry record
The Impact of Oral Health in HIV Patients on Antiretroviral Therapy
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 227
- Enrollment target
NCT04645693: Completed study, sponsored by University of Pennsylvania.
NCT04645693 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 227 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04645693 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 227 participants
- Enrollment target
Study Summary
This is a prospective cohort study designed to investigate the range of metabolic abnormalities observed in patients living with HIV on antiretroviral therapy. This study will also explore the concurrent role of poor oral health in supporting and driving chronic immune activation and inflammation in HIV infection.
Primary Outcome
Decayed, missing and filled surfaces (DMFS) score to assess dental caries. Minimum value is 0 and maximum value is 128 for 28 teeth. Higher scores mean higher levels of dental decay.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 227 participants |
| Start Date | 2021-02-24 |
| Est. Completion | 2026-02-28 |
What the finished NCT04645693 record still lists
NCT04645693 is an observational study that tracks outcomes without assigning an intervention. The registered 227 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04645693 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04645693 about?
NCT04645693 is a clinical study titled "The Impact of Oral Health in HIV Patients on Antiretroviral Therapy". This is a prospective cohort study designed to investigate the range of metabolic abnormalities observed in patients living with HIV on antiretroviral therapy. This study will also explore the concurrent role of poor oral health in supporting and driving chronic immune activation and inflammation in...
What is the current status of trial NCT04645693?
This trial is currently completed. The enrollment target is 227 participants. The study started on 2021-02-24. Estimated completion is 2026-02-28.
Who is sponsoring clinical trial NCT04645693?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04751409 · 227 participants · Phase 2
Evaluating the Impact of Limited Compared With Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Stage II-III Soft Tissue Sarcoma of the Trunk and Extremities
- NCT05742360 · 227 participants
Effect of CPAP on Blood Pressure in Excessively Sleepy Obstructive Sleep Apnea Subtype
- NCT05890352 · 227 participants · Phase 2
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
- NCT05107908 · 228 participants · NA
Neuronal and Behavioral Effects of an Implicit Priming Approach to Improve Eating Behaviors in Obesity
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI